inspire.clinic Warning Letter Details

Summary

Based on limited metadata, inspire.clinic, an online pharmacy or telemedicine clinic, received an FDA warning letter for unlawfully selling unapproved and misbranded drugs to U.S. consumers via the internet. The violations fall under CDER's jurisdiction and involve pharmaceutical products that either lack FDA approval or carry misleading labeling. The company appears to have distributed these products directly to consumers without proper regulatory authorization or compliance with drug marketing requirements.